Child-parent screening for familial hypercholesterolemia (FH) is a population method for identifying children and their parents who are at high risk of premature ischaemic heart disease due to inherited high cholesterol.
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Child-parent screening for familial hypercholesterolemia (FH) is a population method for identifying children and their parents who are at high risk of premature ischaemic heart disease due to inherited high cholesterol. 1 The method links screening with childhood immunisation allowing universal coverage of the population, and identifies FH securely based on cholesterol measurement supported by FH mutation testing. 2 The early identification of FH allows the introduction of preventive treatment before the onset of ischaemic heart disease, and ensures screening happens at the stage in life when a cholesterol measurement is most discriminatory for FH (1-2 years of age). The method has been shown to be feasible and acceptable in a national demonstration project; 3 over 3 years, 10,095 children (median age 13 months) were screened at 92 UK general practices during routine immunisations -84% of parents accepted the offer of screening and 94% said they would have a second child screened by the method if it were offered. 3, 4 Child-parent screening identified one new FH positive individual for every 125 children screened. The method leads naturally to cascade testing in which relatives are tested -half of all first degree relatives being affected. 5 Integrated childparent cascade screening is highly effective and costeffective. 6, 7 It is not known whether access to screening varies across ethnic groups. We used data from the Child-parent Screening Study to investigate this. The ethnic mix of 10,095 children who attended for screening between 2012 and 2015 was compared with the ethnic mix recorded in the Office for National Statistics (ONS) census data for the same age group at a similar point in time, based on a survey of 3,496,750 children. 8 For both surveys ethnicity was self-defined using specified categories (white, mixed, Asian, black and other). Figure 1 (a) (10,095 children screened) and (b) (3,496,750 children in census) shows similar ethnic group proportions indicating that child-parent screening is not preferentially taken up by any one particular ethnic group.
The Health and Social Care Act 2012 includes specific duties for providers and commissioners of NHS screening programmes with regard to reducing health inequalities between the people of England. 9 Under the act, screening programmes should pay particular attention to reaching people in diverse ethnic groups; a requirement that has also been highlighted in other countries. 10 The data from the Childparent Screening Study indicate that this requirement is met in screening for FH in children at the time of immunisation.
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